Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1999
03/09/1999US5879925 Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains
03/09/1999US5879924 Immortalized cell lines for virus growth
03/09/1999US5879921 Nucleic acid from cladosporium strain encoding polypeptide with 75% maximum glucose oxidase activity at 30 degrees celcius, ph between ph 5 to ph 8, hybridizing under medium conditions; used for baking, bleaching and personal care
03/09/1999US5879919 Method of using eukaryotic expression vectors comprising the BK virus enhancer
03/09/1999US5879914 Desulfurizing fossil fuels using transformed microorganism containing recombinant dna from rhodococcus which expresses biocatalyst
03/09/1999US5879912 Method of synthesizing saccharide compositions
03/09/1999US5879911 Cell surface protein expressed on human cortical thymocyte and their use
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879907 Artificial gene coding for authentic human serum albumin, use thereof and method
03/09/1999US5879906 Glucuronide repressors and uses thereof
03/09/1999US5879905 In vivo method of initiating protein synthesis with an amino acid other than methionine
03/09/1999US5879904 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
03/09/1999US5879903 Using gene obtained from streptomyces viridochromogenes as antibiotic resistance marker in transformed bacteria
03/09/1999US5879896 Method of screening for inhibitors of human thyrotropin releasing hormone (TRH) receptor
03/09/1999US5879895 Recombinant bovine herpesvirus type 1 polypeptides and immunoassays
03/09/1999US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer
03/09/1999US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia.
03/09/1999US5879891 Producing electrocompetent yeast strain by pretreating with lithium acetate and dithiothreitol to weaken cell wall structure, introducing exogenous dna having selectable marker to host strain, applying electrical pulse, selecting for
03/09/1999US5879883 Dna sequence coding for human amyloid protein having a point mutation in the transmembrane domain: non-isotopic dna assay for alzheimer's disease
03/09/1999US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors
03/09/1999US5879686 Administering refolded trimeric meningococcal group b porin protein-polysaccharide conjugate to raise immune response in animal
03/09/1999US5879679 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
03/09/1999US5879676 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests
03/09/1999US5879673 Administration of thrombopoietin on a single day only
03/09/1999US5879672 Tie-2 ligand 1
03/09/1999US5879664 Isolated active enzyme obtained from aspergillus
03/09/1999US5879625 Optical selection and collection of DNA fragments
03/09/1999CA2243656A1 Response regulator
03/09/1999CA2208515C Method for generating proteolytic enzymes specific against a selected peptide sequence
03/09/1999CA2171970C A disease resistance gene from maize and its use for disease resistance as a selectable marker and as a gene identification probe
03/09/1999CA2080355C Isolated viral protein cytokine antagonists
03/09/1999CA2038279C Cd25 binding molecules
03/09/1999CA1340427C Genetic modification of endothelial cells
03/09/1999CA1340423C Mycobacterial recombinants and peptides
03/04/1999WO1999010541A1 Phosphoramidate-phosphodiester oligonucleotide chimera as primers
03/04/1999WO1999010539A1 Screening for novel bioactivities
03/04/1999WO1999010538A1 Amplification method for a polynucleotide
03/04/1999WO1999010537A1 A tumor suppressor designated ts10q23.3
03/04/1999WO1999010535A1 A process to study changes in gene expression in stem cells
03/04/1999WO1999010532A1 Methods for identifying or screening agonists for and antagonists to ppar
03/04/1999WO1999010529A1 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use
03/04/1999WO1999010527A2 Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles
03/04/1999WO1999010525A1 A method of treating cancer
03/04/1999WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
03/04/1999WO1999010515A1 Baculovirus artificial chromosomes and methods of use
03/04/1999WO1999010514A1 Fumonosin resistance
03/04/1999WO1999010513A1 Universal chloroplast integration and expression vectors, transformed plants and products thereof
03/04/1999WO1999010512A1 Improved agrobacterium-mediated transformation of plants
03/04/1999WO1999010511A1 Method for increasing the gene expression of saccharose synthase
03/04/1999WO1999010510A2 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999WO1999010509A1 Polynucleotide inhibition of rna destabilization and sequestration
03/04/1999WO1999010508A1 Chimeric transcriptional activators and compositions and uses related thereto
03/04/1999WO1999010507A1 Transglutaminase and gene encoding same
03/04/1999WO1999010506A1 Mosaic protein and restriction endonuclease assisted ligation method for making the same
03/04/1999WO1999010505A2 Production of proteins in eggs
03/04/1999WO1999010504A2 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
03/04/1999WO1999010503A1 Zymogenic protease precursors that can be autocatalytically activated and their use
03/04/1999WO1999010502A1 Human nucleotide pyrophosphohydrolase
03/04/1999WO1999010501A1 Apoptosis-associated nuclease cpan
03/04/1999WO1999010500A1 Nucleic acid molecules coding for a cysteine proteinase of plant origin and their regulating regions
03/04/1999WO1999010499A1 Statin production by fermentation
03/04/1999WO1999010498A2 Genes encoding enzymes for lignin biosynthesis and uses thereof
03/04/1999WO1999010497A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines
03/04/1999WO1999010496A1 Tuberculosis vaccine
03/04/1999WO1999010495A1 Cytokine designated lerk-6
03/04/1999WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/04/1999WO1999010493A1 ATTENUATED AND DOMINANT NEGATIVE VARIANT cDNAs OF STAT6: STAT6b AND STAT6c
03/04/1999WO1999010492A1 Adipocyte-specific protein homologs
03/04/1999WO1999010491A1 New human g-protein coupled receptor
03/04/1999WO1999010490A1 Human galectin-9-like proteins and cdnas encoding these proteins
03/04/1999WO1999010489A1 Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells
03/04/1999WO1999010487A2 Novel transcriptional regulators and uses therefor
03/04/1999WO1999010486A2 Mdm2-specific antisense oligonucleotides
03/04/1999WO1999010485A1 Methods using phage display for selecting internalizing ligands for gene delivery
03/04/1999WO1999010484A1 Rtd receptor
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010479A1 Impaired brca2 function in cells and non-human transgenic animals
03/04/1999WO1999010475A2 Attenuated strains of mycobacteria
03/04/1999WO1999010380A1 Human spa-1 protein and gene coding for the same
03/04/1999WO1999010376A1 Inducible regulatory system and use thereof
03/04/1999WO1999010375A2 Vaccine against hpv
03/04/1999WO1999010369A1 Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
03/04/1999WO1999010368A1 Presenilin-1 gene promoter
03/04/1999WO1999010367A1 Dna molecules encoding human nuclear receptor proteins
03/04/1999WO1999010366A1 High fidelity polymerases and uses thereof
03/04/1999WO1999010364A1 Follistatin-3
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010361A1 Oligonucleotides for identifying precursors of amidated polypeptide hormones
03/04/1999WO1999010358A2 Method for producing nucleic acid polymers
03/04/1999WO1999010337A1 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999010013A1 The use of insulin-like growth factor-i in muscle
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010001A1 Carcinostatic agents
03/04/1999WO1999009830A1 Method of increasing foreign protein expression
03/04/1999WO1999009817A1 Use of mariner transposan in the production of transgenic animals
03/04/1999WO1999009816A1 Process for producing insulin precursor proteins
03/04/1999WO1999009815A1 Vitamin d receptor ablated mice
03/04/1999WO1998056915A3 Artificial antibody polypeptides
03/04/1999WO1998056902A3 Transgenic fish with tissue-specific expression
1 ... 3425 3426 3427 3428 3429 3430 3431 3432 3433 3434 3435 3436 3437 3438 3439 3440 3441 3442 3443 3444 3445 ... 4023